Outlook Therapeutics's total assets for Q2 2025 were $19.08M, an increase of 12.17% from the previous quarter. OTLK total liabilities were $51.54M for the fiscal quarter, a -23.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.